Clinical Evaluation of Laser Therapy Used as an Adjunct to Non-Surgical Treatment of Gum Disease
Clinical Evaluation of WaterLase (iPlus) Laser Therapy Used as an Adjunct to Non-Surgical Treatment of Chronic Periodontitis: A Randomized, Controlled, Split-Mouth Clinical Study
1 other identifier
interventional
23
0 countries
N/A
Brief Summary
The use of lasers to treat various problems in dentistry is growing as it has in medicine. One application is the use of lasers to treat periodontal disease. It has been suggested that the laser may reduce the need for surgical treatment by reducing pockets. The goal of this study is to evaluate the effectiveness of laser treatment for periodontal disease. Laser therapy will be used in addition to traditional non-surgical scaling and root planing (deep cleaning). The information obtained from this study will provide an objective assessment of adjunctive laser therapy compared to conventional periodontal therapy and will attempt to show the benefits, if any, lasers can provide in the treatment of chronic periodontal disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2017
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
July 18, 2019
CompletedFirst Posted
Study publicly available on registry
July 22, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedResults Posted
Study results publicly available
March 5, 2021
CompletedMarch 5, 2021
February 1, 2021
2.9 years
July 18, 2019
January 26, 2021
February 12, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Probing Pocket Depth
This is a measure from base of pocket to gingival margin.
12 months
Sites That Bleed on Probing
Percentage of sites that bleed in response to probing. Bleeding observed within 30 seconds from pocket/sulcus following periodontal probe measurement.
12 months
Gingival Recession
Measure of gingival recession following treatment. This is a measure of the gingival margin from the cement-enamel junction.
12 months
Clinical Attachment Level
Periodontal clinical attachment level following treatment. This is a calculation (clinical attachment level = probing pocket depth + gingival recession).
12 months
Secondary Outcomes (2)
Periodontal Microbiome
12 months
Patient Reported Outcomes: VAS Questionnaire
12 months
Study Arms (2)
SRP + Adjunctive Laser Therapy
EXPERIMENTALLaser therapy used as an adjunct to scaling and root planing
SRP alone
ACTIVE COMPARATORScaling and root planing used as conventional non-surgical periodontal therapy
Interventions
Adjunctive application of laser therapy in the periodontal pocket
Scaling to remove calculus deposits and root planing to smooth root surfaces
Eligibility Criteria
You may qualify if:
- Age 18 years old or older (male or female)
- Healthy without systemic diseases that may adversely effect healing
- Not pregnant and no current plans to become pregnant
- No periodontal treatment in the previous 12 months
- No systemic antibiotic therapy in the previous 6 months
- At least two quadrants with periodontitis (ideally opposite side same jaw)
- Each quadrant must have two or more sites with probing pocket depths ≥ 5mm
- Each quadrant should include interproximal intrabony defect(s)
You may not qualify if:
- Any systemic disease, medication, or habit known to adversely influence bone metabolism and/or wound healing:
- Poorly controlled diabetes (HbA1c \> 7%)
- History of bisphosphonate medications
- History of radiation therapy affecting the proposed treatment site(s)
- History of immunosuppressive medications (e.g. corticosteroids)
- History of tobacco use (current or past tobacco use within the past 1 year)
- Immune compromise caused by disease, treatment or other condition
- Recent history of periodontal surgery (within the previous 2 years)
- Recent history of scaling and root planing (within the previous 12 months)
- Any condition that contraindicates periodontal therapy including surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, Los Angeleslead
- Biolase Inccollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Perry Klokkevold
- Organization
- UCLA Periodontics and Implant Surgery
Study Officials
- PRINCIPAL INVESTIGATOR
Perry R Klokkevold, DDS, MS
UCLA School of Dentistry, Section of Periodontics
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Clinical Dentistry
Study Record Dates
First Submitted
July 18, 2019
First Posted
July 22, 2019
Study Start
January 1, 2017
Primary Completion
December 1, 2019
Study Completion
December 1, 2019
Last Updated
March 5, 2021
Results First Posted
March 5, 2021
Record last verified: 2021-02